Napolitano Antonio Giulio, Monacelli Massimo, Liparulo Valeria, Coviello Eleonora, Pourmolkara Domenico, Avenia Stefano, Polistena Andrea
Thoracic Surgery Unit, Department of Surgical Sciences, Santa Maria della Misericordia University Hospital, University of Perugia Medical School, Perugia, Italy.
Endocrine Surgery Unit, Department of Surgical Sciences, Santa Maria University Hospital, University of Perugia Medical School, Terni, Italy.
Ann Surg Treat Res. 2023 Aug;105(2):76-81. doi: 10.4174/astr.2023.105.2.76. Epub 2023 Aug 1.
Primary hyperparathyroidism (PHPT) is caused by typical adenoma (TA), multiglandular disease (MD), or parathyroid carcinoma (PC), and in a smaller percentage of cases by atypical parathyroid tumor (APT). The objective of this study is the retrospective analysis of clinical features and parathyroid hormone (PTH)/calcium response to surgery in patients who underwent parathyroidectomy for symptomatic PHPT with histological evidence of APT.
We retrospectively reviewed our institutional experience in the management of PHPT from January 2016 to December 2021 focusing on those patients presenting APTs. We analyzed the clinical features of this disease and PTH/calcium response to surgical treatment in APTs compared to the other pathological conditions causing PHPT.
In a cohort of 125 patients with PHPT we found 112 TAs (89.6%), 6 APTs (4.8%), 6 PCs (4.8%), and only 1 MD (0.8%). APTs in comparison to other parathyroid diseases showed peculiar features such as adhesion to the surrounding structures and a frequent intrathyroidal location, which may justify thyroid loboistmectomy adopted in most of the observed cases. APTs showed significantly higher preoperative PTH values compared to TA + MD and were relevant to PC.
Due to its rarity, there is a lack of specific indications in the management of APTs. Biochemical features observed in APT and PC can be related to similar biological behavior. However, some specific features observed preoperatively in some cases of PHPT might suggest presence of an APT, which could be helpful mostly in surgical and postoperative management. Further studies are required to confirm the results of the present preliminary report.
原发性甲状旁腺功能亢进症(PHPT)由典型腺瘤(TA)、多腺体疾病(MD)或甲状旁腺癌(PC)引起,在较小比例的病例中由非典型甲状旁腺肿瘤(APT)引起。本研究的目的是对因有症状的PHPT接受甲状旁腺切除术且有APT组织学证据的患者的临床特征以及甲状旁腺激素(PTH)/钙对手术的反应进行回顾性分析。
我们回顾性分析了2016年1月至2021年12月期间我们机构对PHPT的管理经验,重点关注那些出现APT的患者。我们分析了该疾病的临床特征以及与其他导致PHPT的病理状况相比,APT患者手术治疗后的PTH/钙反应。
在125例PHPT患者队列中,我们发现112例TA(89.6%)、6例APT(4.8%)、6例PC(4.8%),仅有1例MD(0.8%)。与其他甲状旁腺疾病相比,APT具有一些特殊特征,如与周围结构粘连以及常见的甲状腺内位置,这可能解释了在大多数观察病例中采用甲状腺叶切除术的原因。与TA + MD相比,APT术前PTH值显著更高,且与PC相关。
由于APT罕见,在其管理方面缺乏具体指征。在APT和PC中观察到的生化特征可能与相似的生物学行为有关。然而,在某些PHPT病例术前观察到的一些特定特征可能提示存在APT,这在手术及术后管理中可能最有帮助。需要进一步研究来证实本初步报告的结果。